Placebo for Recombinant Human Chymotrypsin(OsrhCT)

DRUG2 trials

Sponsors

Healthgen Biotechnology Corp.

Conditions

Gastric Mucosal LesionPleurisy

Phase 1

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy

Not yet recruitingNCT06525272

Healthgen Biotechnology Corp.Pleurisy

Start: 2024-07-31End: 2025-12-31Target: 72Updated: 2024-07-29

Phase 2

Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.

Active, not recruitingNCT06722664

Healthgen Biotechnology Corp.Gastric Mucosal Lesion

Start: 2024-12-19End: 2025-05-15Target: 336Updated: 2025-04-29